Literature DB >> 26703791

Interstitial pneumonia in two patients with psoriasis during ustekinumab treatment.

Sota Kikuchi1, Yoshinori Umezawa1, Mitsuha Hayashi1, Koichi Yanaba1, Osamu Fukuchi1, Toshihiro Ito1, Akihiko Asahina1, Hidehisa Saeki2, Hidemi Nakagawa1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26703791     DOI： 10.1111/1346-8138.13250

Source DB:  PubMed          Journal:  J Dermatol        ISSN： 0385-2407            Impact factor:   4.005


× No keyword cloud information.
  6 in total

Review 1.  Autoimmunity and autoimmune co-morbidities in psoriasis.

Authors:  Kazuhisa Furue; Takamichi Ito; Gaku Tsuji; Takafumi Kadono; Takeshi Nakahara; Masutaka Furue
Journal:  Immunology       Date:  2018-02-06       Impact factor: 7.397

2.  [Drug-induced interstitial lung disease (DILD) during treatment with ustekinumab].

Authors:  Constantin Sorger; Jan Christoph Simon; Regina Treudler
Journal:  Hautarzt       Date:  2020-04       Impact factor: 0.751

3.  Stelara struck: a case of noninfectious pneumonitis secondary to ustekinumab.

Authors:  Katherine A Despotes; Christine L Vigeland
Journal:  BMC Pulm Med       Date:  2022-07-19       Impact factor: 3.320

4.  Stop Being So Sensitive: An Exceptionally Rare Report of Ustekinumab-Induced Sub-acute Hypersensitivity Pneumonitis.

Authors:  Azka Ali; Jason Chertoff; Christopher Harden; Dara Wakefield; James Wynne
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-09-15

5.  Interstitial Pneumonia in Psoriasis.

Authors:  Hironori Kawamoto; Hiromichi Hara; Shunsuke Minagawa; Takanori Numata; Jun Araya; Yumi Kaneko; Yoshinori Umezawa; Akihiko Asahina; Hidemi Nakagawa; Kazuyoshi Kuwano
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2018-09-20

6.  Characteristics of anti-IL-17/23 biologics-induced interstitial pneumonia in patients with psoriasis.

Authors:  Hanae Miyagawa; Hiromichi Hara; Jun Araya; Shunsuke Minagawa; Takanori Numata; Yoshinori Umezawa; Akihiko Asahina; Hidemi Nakagawa; Kazuyoshi Kuwano
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.